TLR9 and acute lymphoblastic leukemia: One study using TLR agonists in B-cell precursor ALL cell lines revealed that treatment with TLR2 or TLR9 agonists stimulated allogeneic T cell responses demonstrating an important link between innate and adaptive immunity (Corthals et al., 2006).